Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study
Diabetes Mellitus, Type 2
Hypertrophy, Left Ventricular
New-onset diabetes could be strongly predicted by a newly developed risk score using baseline serum glucose concentration (non-fasting), body mass index, serum high-density lipoprotein cholesterol concentration, systolic blood pressure and history of prior use of antihypertensive drugs. Independently of these risk factors, fewer hypertensive patients with left ventricular hypertrophy developed diabetes mellitus if they were treated with losartan than if they were treated with atenolol.